Practical considerations for patients When considering tirzepatide, whether under the brand name Mounjaro or Zepbound, patients should take into account several practical considerations to ensure safe and effective use: Administration and monitoring: Dosage : Begin with a usual initiation dose of 5 mg/0.5 mL injected subcutaneously once a week for Mounjaro and once every two weeks for Zepbound Monitoring : Schedule regular follow-ups to monitor hemoglobin A1c and body weight, adjusting the treatment plan as necessary Blood sugar levels : Maintain regular monitoring of blood sugar levels, especially crucial for those with type 2 diabetes Precautions and safety measures: Pregnancy : Use tirzepatide only if the potential benefit outweighs the risk to the fetus
Losing weight is hard for a plethora of reasons, and it is even harder when someone reaches a level of obesity that impairs their ability to exercise effectively
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education and the Robert Wood Johnson Foundation
Access to prescription medications : If your clinician feels its appropriate, they will prescribe weight loss medications as part of your personalized plan
20% in the SIM alone arm.100 There are currently two phase III trials of SEL, exploring its effectiveness in patients with bridging fibrosis and compensated NASH cirrhosis